Cosima Brucker

ORCID: 0000-0001-7172-5218
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Breast Cancer Therapies
  • Breast Cancer Treatment Studies
  • Estrogen and related hormone effects
  • Reproductive Biology and Fertility
  • Ovarian function and disorders
  • Sperm and Testicular Function
  • Complementary and Alternative Medicine Studies
  • Pelvic floor disorders treatments
  • Medical and Health Sciences Research
  • BRCA gene mutations in cancer
  • Endometriosis Research and Treatment
  • Assisted Reproductive Technology and Twin Pregnancy
  • Reproductive System and Pregnancy
  • HER2/EGFR in Cancer Research
  • Reproductive Health and Contraception
  • Anorectal Disease Treatments and Outcomes
  • Ovarian cancer diagnosis and treatment
  • Menopause: Health Impacts and Treatments
  • Uterine Myomas and Treatments
  • Endometrial and Cervical Cancer Treatments
  • Health and Medical Studies
  • Lung Cancer Research Studies
  • Cancer Treatment and Pharmacology
  • Pelvic and Acetabular Injuries
  • Pregnancy and preeclampsia studies

Paracelsus Medizinische Privatuniversität
2015-2024

Klinik für Frauenheilkunde
2010-2024

Nuremberg Hospital
2014-2024

Clinica Universidad de Navarra
2024

Universitätsklinik für Frauenheilkunde und Geburtshilfe
2016

Universitäts Frauenklinik
1993-2016

Comprehensive Cancer Center Erlangen
2011-2016

Universitätsklinikum Erlangen
2016

Friedrich-Alexander-Universität Erlangen-Nürnberg
2016

Georg Simon Ohm University of Applied Sciences Nuremberg
2013

Luis Chiva Vanna Zanagnolo Denis Querleu Nerea Martín‐Calvo Juan Arévalo‐Serrano and 95 more Mihai Emil Căpîlna Anna Fagotti Ali Kucukmetin Constantijne H. Mom G Chakalova Shamistan Aliyev Mario Malzoni Fabrice Narducci Octavio Arencibia Francesco Raspagliesi Tayfun Toptaş David Cibula Dilyara Kaidarova Mehmet Mutlu Meydanlı Mariana Vide Tavares Dmytro Golub Anna Myriam Perrone Ròbert Póka Dimitrios Tsolakidis Goran Vujić Marcin Jędryka Petra L.M. Zusterzeel Jogchum Jan Beltman Frédéric Goffin Dimitrios Haidopoulos Herman Haller Robert Jach Iryna Yezhova Igor Berlev Margarida Bernardino Rasiah Bharathan Maximilian Lanner Minna M Mäenpää Vladyslav Sukhin Jean‐Guillaume Feron Robert Fruscio Kersti Kukk Jordi Ponce José Ángel Mínguez Daniel Vázquez-Vicente Teresa Castellanos Enrique Chacón Juan Luis Alcázar Nabil Abdalla Özgür Akbayır Sedat Akgöl Elif Akşahin Shamistan Aliyev María Alonso-Espías Игор Алулоски Cláudia Regina Furquim de Andrade Nikola Badzakov Rosa Barrachina Giorgio Bogani Eduard-Aexandru Bonci Hélène Bonsang‐Kitzis Félix Boria Cosima Brucker L. M. Cardenas Andrea Casajuana Pere Cavallé Jorge Cea Benito Chiofalo Gloria Cordeiro Pluvio Coronado María Cuadra Javier Dı́ez Teresa Diniz da Costa Santiago Domingo Lukáš Dostálek Fuat Demirkiran Diego Erasun Mathias K. Fehr Sergi Fernández-González Annamaria Ferrero Soledad Fidalgo Gabriel Fiol Khadra Galaal José Alenza García Gerhard Gebauer Fabio Ghezzi Juan Gilabert–Estellés Nana Gomes Elisabete Gonçalves Virginia González Frédéric Grandjean Miriam Guijarro Frédéric Guyon Jolien Haesen Ginés Hernández-Cortes Sofía Herrero Imre Pete Ioannis Kalogiannidis Erbil Karaman Andreas Kavallaris

Minimally invasive surgery in cervical cancer has demonstrated recent publications worse outcomes than open surgery. The primary objective of the SUCCOR study, a European, multicenter, retrospective, observational cohort study was to evaluate disease-free survival patients with stage IB1 (FIGO 2009) undergoing vs minimally radical hysterectomy. As secondary objective, we aimed investigate association between protective surgical maneuvers and risk relapse. We obtained data from 1272 that...

10.1136/ijgc-2020-001506 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2020-08-12
Jacobus Pfisterer Catherine Shannon Klaus Baumann Jörn Rau Philipp Harter and 95 more Florence Joly Jalid Sehouli Ulrich Canzler Barbara Schmalfeldt Andrew P Dean Alexander Hein Alain G. Zeimet Lars Hanker Thierry Petit Frederik Marmé Ahmed El‐Balat Rosalind Glasspool Nikolaus de Gregorio Sven� Mahner Tarek Meniawy Tjoung‐Won Park‐Simon Marie‐Ange Mouret‐Reynier Cristina Costan Werner Meier Alexander Reinthaller Jeffrey C. Goh Tifenn L’Haridon Sally Baron Hay Stefan Kommoss Andreas du Bois Jean‐Emmanuel Kurtz Sven Ackermann C. Anthuber Mustafa Aydoğdu Angelika Baldauf Wolfgang Bauer Dirk Behringer Antje Belau Alexandra Bender Cosima Brucker Alexander Burges Ulrich Canzler Trygve Daabach Dominik Denschlag Mustafa Deryal Steffen Dörfel Juliane Ebert Ahmed El-Balat Tanja Fehm Susanne Maria Feidicker Gabriele Feisel-Schwickardi R. Felberbaum Matthias Frank Gerhard Gebauer Bernd Gerber Axel Gerhardt Andrea Gräfe Martin Grießhammer Eva‐Maria Grischke Isolde Gröll Martina Gropp‐Meier Dietrich Hager Volker Hanf Carla Hannig Peer Hantschmann Philipp Harter Tanja Hauzenberger Uwe Herwig Martin Heubner Carsten Hielscher Felix Hilpert T Hitschold Manfred Hofmann Christian Jackisch Wolfgang Janni Ludwig Kiesel Yon‐Dschun Ko H. Koch Petra Krabisch Peter Krieger Thomas Kubin Thorsten Kühn Björn Lampe P. Ledwon Sabine Lemster B. Lex Clemens Liebrich Ralf Lorenz Hans-Joachim Lück Sven� Mahner Peter Mallmann Frederik Marmé Werner Meier Wolfgang Meinerz Götz Menke Volker Möbus Thomas Müller Volker Müller Tanja Neunhöffer Angelika Ober

10.1016/s1470-2045(20)30142-x article EN The Lancet Oncology 2020-04-16

Increasing effort has been put in the implementation and certification of breast centers order to establish standardized, quality assured health care for cancer patients. The aim this analysis was investigate whether patients treated certified (CBC) have a favorable prognosis as compared outside treatment units.The data 3,940 with invasive nonmetastatic were analyzed regard differences patient tumor characteristics crude overall survival according diagnosis or CBC Middle Franconia, Germany....

10.1159/000329601 article EN Onkologie 2011-01-01

The multicenter, randomized, phase IV, intergroup AGO-B WSG PreCycle trial (NCT03220178) evaluated the impact of CANKADO-based electronic patient-reported outcome (ePRO) assessment on quality life (QoL) in hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer (MBC) patients receiving palbociclib and an aromatase inhibitor + fulvestrant. CANKADO PRO-React, a European Union-registered medical device, is interactive autonomous...

10.1016/j.annonc.2023.05.003 article EN cc-by-nc-nd Annals of Oncology 2023-05-17
Daniel Vázquez-Vicente Félix Boria Teresa Castellanos Mónica Gutiérrez Enrique Chacón and 95 more Nabil Manzour José Ángel Mínguez Nerea Martín‐Calvo Juan Luis Alcázar Luis Chiva Vanna Zanagnolo Denis Querleu Juan Arévalo‐Serrano Mihai Emil Căpîlna Anna Fagotti Ali Kucukmetin Constantijne H. Mom G Chakalova Shamistan Aliyev Mario Malzoni Fabrice Narducci Octavio Arencibia Francesco Raspagliesi Tayfun Toptaş David Cibula Dilyara Kaidarova Mehmet Mutlu Meydanlı Mariana Vide Tavares Dmytro Golub Anna Myriam Perrone Ròbert Póka Dimitrios Tsolakidis Goran Vujić Marcin Jędryka Petra L.M. Zusterzeel Jogchum Jan Beltman Frédéric Goffin Dimitrios Haidopoulos Herman Haller Robert Jach Iryna Yezhova И. В. Берлев Margarida Bernardino Rasiah Bharathan Maximilian Lanner Minna M Mäenpää Vladyslav Sukhin Jean‐Guillaume Feron Robert Fruscio Kersti Kukk Jordi Ponce Nabil Abdalla Özgür Akbayır Sedat Akgöl Elif Akşahin Shamistan Aliyev María Alonso-Espías Игор Алулоски Cláudia Regina Furquim de Andrade Nikola Badzakov Rosa Barrachina Giorgio Bogani Eduard-Aexandru Bonci Hélène Bonsang‐Kitzis Cosima Brucker L. M. Cardenas Andrea Casajuana Pere Cavallé Jorge Cea Benito Chiofalo Gloria Cordeiro Pluvio Coronado María Cuadra Javier Dı́ez Teresa Diniz da Costa Santiago Domingo Lukáš Dostálek Fuat Demirkiran Diego Erasun Mathias K. Fehr Sergi Fernández-González Annamaria Ferrero Soledad Fidalgo Gabriel Fiol Khadra Galaal José Alenza García Gerhard Gebauer Fabio Ghezzi Juan Gilabert–Estellés Nana Gomes Elisabete Gonçalves Virginia González Frédéric Grandjean Miriam Guijarro Frédéric Guyon Jolien Haesen Ginés Hernández-Cortes Sofía Herrero Imre Pete Ioannis Kalogiannidis

<h3>Objective</h3> The aim of this study was to compare the incidence intra-operative and post-operative complications in open minimally invasive radical hysterectomy for patients with early-stage cervical cancer. <h3>Methods</h3> Data were collected from SUCCOR database 1272 stage IB1 cancer (International Federation Gynecology Obstetrics (FIGO), 2009) who underwent Europe between January 2013 December 2014. We reviewed duration surgeries, estimated blood loss, length hospital stay,...

10.1136/ijgc-2023-004657 article EN cc-by-nc-nd International Journal of Gynecological Cancer 2024-01-10

In Brief Objective: To investigate endometrial safety by assessment of biopsy samples and the tolerability efficacy special Actaea or Cimicifuga racemosa extract (CR BNO 1055). Design: Four hundred postmenopausal women with symptoms related to estrogen deficiency were enrolled into a prospective, open-label, multinational, multicenter study. Treatment duration (daily dose corresponds 40 mg herbal drug) was 52 weeks. determine probability hyperplasia more serious adverse outcome, point...

10.1097/01.gme.0000196813.34247.e2 article EN Menopause The Journal of The North American Menopause Society 2006-07-01

In order to assess the role of binucleate giant oocytes for generating digynic triploidy, we studied their frequency, maturation patterns and chromosomal complements at metaphase II (MII) or after fertilization.Uncleaved, zygotes were incubated with podophyllotoxin vinblastine, treated hypotonic solution fixed by a gradual fixation method. Giant MII directly subjected treatment. The chromosomes stained Giemsa.A total 7065 collected during study period, which 18 (0.26%) classified as cells....

10.1093/humrep/17.9.2388 article EN Human Reproduction 2002-08-29

10.1016/s0015-0282(97)81377-5 article EN publisher-specific-oa Fertility and Sterility 1997-04-01

Objectives To investigate the real-life clinical experience of NuvaRing® users in Germany.Methods An open-label, prospective, uncontrolled, non-randomized, multicentre post-marketing surveillance study was conducted by 1204 gynaecologists amongst 5823 women requesting contraception. The underwent routine examinations and contraceptive counselling, were assessed after three six cycles use.Results: Good cycle control observed there a reduction irregularity inter-menstrual bleeding, bleeding...

10.1080/13625180701577122 article EN The European Journal of Contraception & Reproductive Health Care 2008-01-01

Abstract Background Due to the lack of prospective data, current treatment male breast cancer (MBC) is based on information obtained from retrospective analysis or by extrapolation studies female patients. In this prospectively enrolled cohort study, we retrospectively examined survival effect tamoxifen in MBC Methods 448 patients with were treated between May 2009 and June 2018. The primary endpoint was disease-free (DFS). Results Between 2018, men identified, a median age at diagnosis 69...

10.1038/s41416-020-0857-z article EN cc-by British Journal of Cancer 2020-05-04

Intra-ovarian regulation of follicular maturation is modulated by various factors. Among these, growth factors are important local actors. We examined the immunohistochemical localization transforming factor alpha (TGF-alpha), epidermal (EGF) and receptor (EGF-R) in 18 human ovaries. The concentration TGF-alpha EGF fluid was measured ELISA. detected oocytes primordial early preantral follicles. Furthermore, staining observed granulosa cells follicles theca preantral, antral preovulatory...

10.1093/humrep/13.8.2199 article EN Human Reproduction 1998-08-01

Previously, we provided evidence for the presence of a class muscarinic receptors on human luteinized granulosa cells (human GC) that is linked to transient increases in intracellular free calcium levels, but not steroid production. The precise nature receptor known, and neither its function nor source natural ligand acetylcholine (ACh) clear. To address these issues used RT-PCR approaches isolated complementary DNAs corresponding M1 subtype from reverse transcribed GC messenger ribonucleic...

10.1210/jcem.84.5.5648 article EN The Journal of Clinical Endocrinology & Metabolism 1999-05-01

The growing popularity and acceptance of integrative medicine is evident both among patients the oncologists treating them. As little data are available regarding health-care professionals' knowledge, attitudes, practices relating to topic, a nationwide online survey was designed.Over period 11 weeks (from July 15 September 30, 2014) self-administered, 17-item sent all 676 members Research Group on Gynecological Oncology (Arbeitsgemeinschaft Gynäkologische Onkologie) in German Cancer...

10.1007/s00404-017-4420-y article EN cc-by Archives of Gynecology and Obstetrics 2017-06-07

Background. Breast cancer patients often use complementary and alternative medicine, but few prospectively collected data on the topic are available specifically for postmenopausal breast patients. A large prospective study was therefore conducted within a noninterventional in order to identify characteristics of interested integrative medicine. Methods. The EvAluate-TM is prospective, multicenter which treatment with aromatase inhibitor letrozole evaluated women hormone receptor–positive...

10.1177/1534735416668575 article EN cc-by-nc Integrative Cancer Therapies 2016-09-14

Abstract Adjuvant treatment of patients with early-stage breast cancer (BC) should include an aromatase inhibitor (AI). Especially a high recurrence risk might benefit from upfront therapy AI for minimum five years. Nevertheless, not much is known about the patient selection this population in clinical practice. Therefore, study analyzed prognosis and characteristics postmenopausal selected five-year letrozole therapy. From 2009 to 2011, 3529 were enrolled into adjuvant phase IV PreFace...

10.1055/a-2238-3153 article EN cc-by-nc-nd Geburtshilfe und Frauenheilkunde 2024-02-01

Introduction Circulating levels of the antiangiogenic protein vasoinhibin, a fragment prolactin, are interest in vasoproliferative retinopathies, preeclampsia, and peripartum cardiomyopathy; however, it is difficult to determine circulating vasoinhibin due lack quantitative assays. Methods This study used human serum samples assess concentration bioactivity using novel enzyme-linked immunosorbent assay (ELISA) for which employs an anti-vasoinhibin monoclonal antibody, umbilical vein...

10.3389/fendo.2024.1345996 article EN cc-by Frontiers in Endocrinology 2024-04-29
Coming Soon ...